West Pharmaceutical Services Balance Sheet
NYSE: WSTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
West Pharmaceutical Services financial position
At the end of fiscal 2025, West Pharmaceutical Services reported total assets of $4.27 billion, up 17.2% from a year earlier against total liabilities of $1.09 billion. Shareholders' equity stood at $3.18 billion, or 74.4% of assets. The company held $791.3 million in cash and equivalents against $202.8 million of debt, a net cash position of $588.5 million.
The current ratio (current assets divided by current liabilities) was 3.02, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.06.
Summary generated from market data by MetaCap's automated system. Methodology
West Pharmaceutical Services balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 791.30M | 484.60M | 853.90M | 894.30M | 762.60M | 615.50M | 439.10M | 337.40M | 235.90M | 203.00M |
| Receivables | 574.40M | 552.50M | 512.00M | 507.40M | 489.00M | 385.30M | 319.30M | 288.20M | 253.20M | 200.50M |
| Inventory | 443.90M | 377.00M | 434.70M | 414.80M | 378.40M | 321.30M | 235.70M | 214.50M | 215.20M | 199.30M |
| Total Current Assets | 1.98B | 1.54B | 1.94B | 1.92B | 1.74B | 1.37B | 1.06B | 894.40M | 743.50M | 641.90M |
| Property, Plant & Equipment | 1.73B | 1.58B | 1.41B | 1.16B | 1.06B | 943.20M | 839.30M | 822.00M | 855.00M | 778.30M |
| Goodwill | 109.90M | 106.00M | 108.50M | 107.30M | 109.90M | 111.10M | 107.80M | 105.80M | 107.70M | 103.00M |
| Intangible Assets | 7.70M | 10.80M | 15.10M | 18.40M | 23.00M | 30.50M | 29.80M | 20.30M | 21.70M | 23.30M |
| Total Assets | 4.27B | 3.64B | 3.83B | 3.62B | 3.31B | 2.79B | 2.34B | 1.98B | 1.86B | 1.72B |
| Accounts Payable | 253.70M | 239.30M | 242.40M | 215.40M | 232.20M | 213.10M | 156.80M | 130.40M | 138.10M | 122.00M |
| Short-Term Debt | 0 | 0 | 134.00M | 2.20M | 44.20M | 2.30M | 2.30M | 100.00K | 0 | 2.40M |
| Total Current Liabilities | 654.90M | 550.40M | 671.80M | 519.00M | 594.10M | 503.40M | 341.60M | 283.70M | 279.50M | 241.00M |
| Long-Term Debt | 202.80M | 202.60M | 72.80M | 206.70M | 208.80M | 252.90M | 255.00M | 196.00M | 197.00M | 226.20M |
| Total Liabilities | 1.09B | 961.10M | 948.50M | 931.90M | 978.40M | 939.30M | 768.20M | 582.60M | 582.90M | 599.20M |
| Shareholders' Equity | 3.18B | 2.68B | 2.88B | 2.68B | 2.34B | 1.85B | 1.57B | 1.40B | 1.28B | 1.12B |
| Retained Earnings | 4.37B | 3.96B | 3.52B | 2.99B | 2.46B | 1.85B | 1.55B | 1.35B | 1.18B | 1.07B |
| Total Debt | 202.80M | 202.60M | 206.80M | 208.90M | 253.00M | 255.20M | 257.30M | 196.10M | 197.00M | 228.60M |
| Net Cash (Debt) | 588.50M | 282.00M | 647.10M | 685.40M | 509.60M | 360.30M | 181.80M | 141.30M | 38.90M | -25.60M |
| Shares Outstanding | 72.00M | 72.30M | 73.50M | 74.10M | 74.20M | 74.00M | 74.10M | 74.10M | 73.90M | 73.10M |
This table shows 10 annual periods of West Pharmaceutical Services's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow WST's reporting calendar. What is a balance sheet?